These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34828364)

  • 1. The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics.
    Austin-Zimmerman I; Wronska M; Wang B; Irizar H; Thygesen JH; Bhat A; Denaxas S; Fatemifar G; Finan C; Harju-Seppänen J; Giannakopoulou O; Kuchenbaecker K; Zartaloudi E; McQuillin A; Bramon E
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of antidepressants and antipsychotics with lipid parameters: Do
    Richards-Belle A; Austin-Zimmerman I; Wang B; Zartaloudi E; Cotic M; Gracie C; Saadullah Khani N; Wannasuphoprasit Y; Wronska M; Dawda Y; Osborn DP; Bramon E
    J Psychopharmacol; 2023 Apr; 37(4):396-407. PubMed ID: 36772859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequencies of
    Scherf-Clavel M; Weber H; Unterecker S; Müller DJ; Deckert J
    World J Biol Psychiatry; 2024 Apr; 25(4):214-221. PubMed ID: 38493365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients.
    Jessel CD; Mostafa S; Potiriadis M; Everall IP; Gunn JM; Bousman CA
    Pharmacogenet Genomics; 2020 Sep; 30(7):145-152. PubMed ID: 32433340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis.
    Li D; Pain O; Fabbri C; Wong WLE; Lo CWH; Ripke S; Cattaneo A; Souery D; Dernovsek MZ; Henigsberg N; Hauser J; Lewis G; Mors O; Perroud N; Rietschel M; Uher R; Maier W; Baune BT; Biernacka JM; Bondolfi G; Domschke K; Kato M; Liu YL; Serretti A; Tsai SJ; Weinshilboum R; ; McIntosh AM; Lewis CM
    Transl Psychiatry; 2024 Jul; 14(1):296. PubMed ID: 39025838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study.
    Naujokaitis D; Asmoniene V; Kadusevicius E
    Medicine (Baltimore); 2021 Mar; 100(11):e24545. PubMed ID: 33725937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication.
    Walden LM; Brandl EJ; Tiwari AK; Cheema S; Freeman N; Braganza N; Kennedy JL; Müller DJ
    Psychiatry Res; 2019 Sep; 279():111-115. PubMed ID: 29699889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O-Desmethylvenlafaxine Concentrations in a Large Patient Cohort.
    Kringen MK; Bråten LS; Haslemo T; Molden E
    J Clin Psychopharmacol; 2020; 40(2):137-144. PubMed ID: 32134850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder.
    Brandl EJ; Tiwari AK; Zhou X; Deluce J; Kennedy JL; Müller DJ; Richter MA
    Pharmacogenomics J; 2014 Apr; 14(2):176-81. PubMed ID: 23545896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis.
    Milosavljevic F; Bukvic N; Pavlovic Z; Miljevic C; Pešic V; Molden E; Ingelman-Sundberg M; Leucht S; Jukic MM
    JAMA Psychiatry; 2021 Mar; 78(3):270-280. PubMed ID: 33237321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response.
    Scherf-Clavel M; Weber H; Wurst C; Stonawski S; Hommers L; Unterecker S; Wolf C; Domschke K; Rost N; Brückl T; Lucae S; Uhr M; Binder EB; Menke A; Deckert J
    Pharmacopsychiatry; 2022 Sep; 55(5):246-254. PubMed ID: 35839823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.
    de Leon J; Armstrong SC; Cozza KL
    Psychosomatics; 2006; 47(1):75-85. PubMed ID: 16384813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation.
    Ragia G; Pallikarou M; Manolopoulou Y; Vorvolakos T; Manolopoulos VG
    Pharmacogenomics; 2024; 25(5-6):217-229. PubMed ID: 38884939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Routine Cytochrome P450 2D6 and 2C19 Genotyping on Antipsychotic Drug Persistence in Patients With Schizophrenia: A Randomized Clinical Trial.
    Jürgens G; Andersen SE; Rasmussen HB; Werge T; Jensen HD; Kaas-Hansen BS; Nordentoft M
    JAMA Netw Open; 2020 Dec; 3(12):e2027909. PubMed ID: 33284338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors.
    Spigset O; Hedenmalm K; Dahl ML; Wiholm BE; Dahlqvist R
    Acta Psychiatr Scand; 1997 Nov; 96(5):379-84. PubMed ID: 9395157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment.
    van de Bilt MT; Prado CM; Ojopi EP; Sousa RT; Loch AA; Zanetti MV; Talib LL; Gattaz WF
    Schizophr Res; 2015 Oct; 168(1-2):587-8. PubMed ID: 26298540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
    Kirchheiner J; Nickchen K; Bauer M; Wong ML; Licinio J; Roots I; Brockmöller J
    Mol Psychiatry; 2004 May; 9(5):442-73. PubMed ID: 15037866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study.
    Honeycutt DC; Blom TJ; Ramsey LB; Strawn JR; Bruns KM; Welge JA; Patino LR; Singh MK; DelBello MP
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):42-51. PubMed ID: 38377518
    [No Abstract]   [Full Text] [Related]  

  • 20. CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort.
    Ivanov HY; Grigorova D; Lauschke VM; Velinov B; Stoychev K; Kyosovska G; Shopov P
    J Pers Med; 2022 Jul; 12(7):. PubMed ID: 35887684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.